Author

Yusuke Ito

Observed names: Ito, Yusuke, YUSUKE ITO

Institutions: Yokohama City University Hospital, Yokohama City University

Observed institutions: Yokohama City University Hospital, Yokohama City University

ORCID: 0000-0003-4325-7722

Observed ORCID: 0000-0003-4325-7722

OpenAlex ID: A5020128388

[177Lu]Lu-PSMA-617 in Patients with Progressive PSMA+ mCRPC Treated With or Without Prior Taxane-Based Chemotherapy: A Phase 2, Open-Label, Single-Arm Trial in Japan

2025 · Kouji Izumi, Ryuji Matsumoto, et al. · Cancers · 3

Enzalutamide Prolonged the Duration of Drug Use in Comparison to Abiraterone Acetate and Cabazitaxel after Upfront Docetaxel: A Large Japanese Database Study

2024 · Katsuya Yamaguchi, Takashi Kawahara, et al. · Diseases · 1

Sequential Treatment and Survival Outcomes According to Abiraterone Timing in High-Risk mHSPC: A Real-World Propensity-Matched Study

2025 · Tomohiko Aigase, Koichi Uemura, et al. · Research Square

Identification of Factors Contributing to Testosterone Recovery After Hormone Therapy Combined With External Radiation Therapy

2024 · YUMIKO YOKOMIZO, YUSUKE ITO, et al. · In Vivo

Additional file 5: Figure S3. of JunB promotes cell invasion, migration and distant metastasis of head and neck squamous cell carcinoma

2016 · Hyakusoku, Hiroshi, Sano, Daisuke, et al. · Figshare

Works count: 8

Citation count: 4

H-index: 1

I10-index: